Mr Mrs Miss Ms Dr Other

Dr
Owain
Summers

Patent Director

York Office

Electronics

Telephone. +44(0) 1904 732 120
Email. [email protected]

Experience

With a background in theoretical physics, Owain has expertise in the fields of physics, electronics and telecommunications, with a particular focus on user equipment, base stations, computer software and 3GPP-related telecommunications standards including 3G, LTE, LTE-A, 4G and 5G (NR).

In addition to having drafted patent applications in these fields, he has significant experience of patent application prosecution at the European Patent Office, including having represented clients at numerous examination Oral Proceedings at the EPO. Owain has also prosecuted patent applications at the UK IPO and worked on oppositions at the EPO.

Owain entered the patent profession in 2013, joining HGF at their York office. In 2016, he qualified as a European Patent Attorney and a Chartered Patent Attorney.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MPHYS

MPhys in Theoretical Physics

PHD

in Physics

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate in Intellectual Property

Publications

Exam Success!

View publication online

CSR

Owain has mentored junior colleagues to assist in their preparation for the European Qualifying Examinations, and has also acted as a tutor to assist in preparation for the European Qualifying Examinations and UK final Qualifying Examinations for a Patent Attorney.

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.